BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17186461)

  • 1. Mutations of presenilin genes in dilated cardiomyopathy and heart failure.
    Li D; Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Partain J; Nixon RR; Allen CN; Irwin RP; Jakobs PM; Litt M; Hershberger RE
    Am J Hum Genet; 2006 Dec; 79(6):1030-9. PubMed ID: 17186461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.
    Cai Y; An SS; Kim S
    Clin Interv Aging; 2015; 10():1163-72. PubMed ID: 26203236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.
    Jiang H; Jayadev S; Lardelli M; Newman M
    J Alzheimers Dis; 2018; 66(4):1323-1339. PubMed ID: 30412492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.
    Galla L; Redolfi N; Pozzan T; Pizzo P; Greotti E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
    Braggin JE; Bucks SA; Course MM; Smith CL; Sopher B; Osnis L; Shuey KD; Domoto-Reilly K; Caso C; Kinoshita C; Scherpelz KP; Cross C; Grabowski T; Nik SHM; Newman M; Garden GA; Leverenz JB; Tsuang D; Latimer C; Gonzalez-Cuyar LF; Keene CD; Morrison RS; Rhoads K; Wijsman EM; Dorschner MO; Lardelli M; Young JE; Valdmanis PN; Bird TD; Jayadev S
    Ann Clin Transl Neurol; 2019 Apr; 6(4):762-777. PubMed ID: 31020001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity.
    Nornes S; Newman M; Verdile G; Wells S; Stoick-Cooper CL; Tucker B; Frederich-Sleptsova I; Martins R; Lardelli M
    Hum Mol Genet; 2008 Feb; 17(3):402-12. PubMed ID: 17981814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
    Campion D; Dumanchin C; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Anterion C; Michon A; Martin C; Charbonnier F; Raux G; Camuzat A; Penet C; Mesnage V; Martinez M; Clerget-Darpoux F; Brice A; Frebourg T
    Am J Hum Genet; 1999 Sep; 65(3):664-70. PubMed ID: 10441572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations.
    Ikeuchi T; Kaneko H; Miyashita A; Nozaki H; Kasuga K; Tsukie T; Tsuchiya M; Imamura T; Ishizu H; Aoki K; Ishikawa A; Onodera O; Kuwano R; Nishizawa M
    Dement Geriatr Cogn Disord; 2008; 26(1):43-9. PubMed ID: 18587238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Course MM; Gudsnuk K; Keene CD; Bird TD; Jayadev S; Valdmanis PN
    Brain; 2023 Feb; 146(2):507-518. PubMed ID: 35949106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.
    Yang Y; Bagyinszky E; An SSA
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach.
    Delabio R; Rasmussen L; Mizumoto I; Viani GA; Chen E; Villares J; Costa IB; Turecki G; Linde SA; Smith MC; Payão SL
    J Alzheimers Dis; 2014; 42(3):757-60. PubMed ID: 24927704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy.
    Li XY; Cui Y; Jing D; Xie K; Zhong X; Kong Y; Wang Y; Chu M; Wang C; Wu L
    Alzheimer Dis Assoc Disord; 2021 Jul-Sep 01; 35(3):208-213. PubMed ID: 33973882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.